INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Feb 06, 2014 |
VP Reg Dev & Med Safety
Trans History: 288
|
VP Reg Dev & Med Safety | Form 5 | Other acquisition or disposition | -- | -- | 1,200 |
| Jan 14, 2014 |
VP Controller and Asst Treasur
Trans History: 372
|
VP Controller and Asst Treasur | Form 4 | Other acquisition or disposition | -- | -- | 4,066 |
| Jan 06, 2014 |
Director
Trans History: 282
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 9,000 |
| Jan 03, 2014 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Other acquisition or disposition | -- | -- | 1,589 |
| Dec 26, 2013 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Other acquisition or disposition | -- | -- | 1,589 |
| Dec 20, 2013 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Other acquisition or disposition | -- | -- | 1,589 |
| Dec 20, 2013 |
Director, President Regeneron Laboratori
Trans History: 617
|
Director, President Regeneron Laboratori | Form 4 | Other acquisition or disposition | -- | -- | 5,591 |
| Dec 19, 2013 |
SVP Administration & Asst Secr
Trans History: 645
|
SVP Administration & Asst Secr | Form 4 | Other acquisition or disposition | -- | -- | 5,618 |
| Dec 19, 2013 |
SVP Administration & Asst Secr
Trans History: 645
|
SVP Administration & Asst Secr | Form 4 | Other acquisition or disposition | -- | -- | 750 |
| Dec 19, 2013 |
SVP Research and Development S
Trans History: 660
|
SVP Research and Development S | Form 4 | Other acquisition or disposition | -- | -- | 20,000 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.